Genprex TUSC2 Research to Be Presented at GSA 2026
Genprex said research on TUSC2 gene therapy and cellular resilience will be presented at the GSA 2026 Annual Scientific Meeting.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Genprex to Present TUSC2 Research at GSA 2026 Meeting
Genprex said it will present research from a sponsored collaboration with Meharry Medical College at the Gerontological Society of America 2026 Annual Scientific Meeting. The research explores TUSC2, the therapeutic gene used in Reqorsa Gene Therapy.